Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dexmet Corporation is a leading manufacturer of precision expanded metal foils and polymers used in high-performance applications across the medical, aerospace, and energy sectors. The company specializes in proprietary MicroGrid and PolyGrid technologies, providing highly engineered mesh materials for medical implants, surgical meshes, and diagnostic components. Their products are critical in the development of advanced medical devices, offering precise control over open area, weight, and conductivity for applications such as orthopedic implants and cardiovascular stents. Since its acquisition by PPG in 2019, Dexmet has continued to leverage its material science expertise to expand its reach in specialized industrial and healthcare markets. The company is headquartered in Wallingford, Connecticut, where it maintains advanced manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dexmet.